Track BIO-UV Group S.A.'s EBIT ($-21M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), ALTUV.PA shows a EBIT of $-21M. That compares with $4.3M in the prior-year period — down 592.4% year over year. That is below the sector sector average of $2.5T. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ALTUV.PA's EBIT is now $-21M (was $4.3M) — a 592.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BIO-UV Group S.A. is outperforming or lagging.
The its sector sector average EBIT is about $2.5T. BIO-UV Group S.A. is at $-21M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how ALTUV.PA stacks up against individual peers as well.
Tracking ALTUV.PA's ebit over time shows whether BIO-UV Group S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $-21M That compares with $4.3M in the prior-year period — down 592.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has BIO-UV Group S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-21M) with ownership activity and broader fundamentals.